skinny.

Latest / Ageless Future

Regulation, Innovation, and Access: Understanding the Evolving Landscape of Peptides

In this session, Regan Archibald explores recent regulatory changes affecting peptides and what they could mean for clinicians, patients, and compounding pharmacies. He outlines how shifting FDA classifications may influence access to certain compounds while highlighting the broader tension between innovation, safety oversight, and pharmaceutical economics. The discussion also provides an overview of several commonly discussed peptides, explaining their origins as naturally occurring or derived molecules and their growing interest within personalized approaches to health. Throughout…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.